Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation

Journal of Thrombosis and Thrombolysis

Volumn 35, Issue 4, 2013, Pages 450-455

  Mok, Michael ^a   Urena, Marina ^a   Nombela Franco, Luis ^a   Ribeiro, Henrique Barbosa ^a   Allende, Ricardo ^a   Delarochellière, Robert ^a   Doyle, Daniel ^a   Dumont, Eric ^a   Côté, Mélanie ^a   Rodés Cabau, Josep ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Antithrombotic; Atrial fibrillation; Stroke; Transcatheter aortic valve implantation

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DABIGATRAN; PRASUGREL; RIVAROXABAN; TICAGRELOR; WARFARIN;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; AORTA VALVE PROSTHESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS GRAFT; DRUG PREFERENCE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; THROMBOEMBOLISM; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; FEMALE; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 84878479410     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0859-7     Document Type: Article

References (50)

1. Falk RH (2001) Atrial fibrillation. N Engl J Med 344:1067-1078
2. Chugh SS, Blackshear JL, Shen WK et al (2001) Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 37:371-378
3. Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370-2375
4. Heeringa J, van der Kuip DA, Hofman A et al (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27:949-953
5. Psaty BM, Manolio TA, Kuller LH et al (1997) Incidence and risk factors for atrial fibrillation in older adults. Circulation 96:2455-2461
6. Cribier A, Eltchaninoff H, Bash A et al (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. First human case description. Circulation 106:3006-3008
7. Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597-1607
8. Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187-2198
9. Rodes-Cabau J (2012) Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 9:15-29
10. Rodes-Cabau J, Webb JG, Cheung A et al (2010) Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 55:1080-1090
11. Piazza N, Grube E, Gerckens U et al (2008) Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4:242-249
12. Tamburino C, Capodanno D, Ramondo A et al (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123:299-308
13. Bosmans JM, Kefer J, de Bruyne B et al (2011) Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg 12:762-767
14. Gilard M, Eltchaninoff H, Iung B et al (2012) Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366:1705-1715
15. Motloch LJ, Reda S, Rottlaender D et al (2011) Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement. Ann Thorac Surg 93:124-131
16. Amat-Santos IJ, Rodes-Cabau J, Urena M et al (2012) Incidence, predictive factors and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol 59:178-188
17. Nuis RJ, Van Mieghem NM, Schultz CJ et al (2012) Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol 109:1637-1643
18. Linke A (2012). Treatment of high risk aortic stenosis patients with transcatheter Medtronic CoreValve implantation. CoreValve ADVANCE. Paper presented at Transcatheter Valve Therapies, 2-5 June 2012
19. Wendler O (2012). 30-day outcome from the SOURCE XT TAVI post-approval study. Paper presented at EuroPCR 2012
20. Shahian DM, O'Brien SM, Filardo G et al (2009) The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1 - coronary artery bypass grafting surgery. Ann Thorac Surg 88:S2-S22
21. Faxon DP, Eikelboom JW, Berger PB et al (2011) Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. Thromb Haemost 106:572-584
22. Benjamin EJ, Levy D, Vaziri SM et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840-844
23. Cox JL (1993) A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg 56:405-409
24. Mehta RH, Dabbous OH, Granger CB et al (2003) Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 92:1031-1036
25. Al-Khatib SM, Pieper KS, Lee KL et al (2001) Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. Am J Cardiol 88:76-79
26. Lau DH, Huynh LT, Chew DP et al (2009) Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol 104:1317-1323
27. Kinjo K, Sato H, Sato H et al (2003) Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 92:1150-1154
28. Bramer S, van Straten AH, Soliman Hamad MA et al (2010) The impact of new-onset postoperative atrial fibrillation on mortality after coronary artery bypass grafting. Ann Thorac Surg 90:443-449
29. Mariscalco G, Klersy C, Zanobini M et al (2008) Atrial fibrillation after isolated coronary surgery affects late survival. Circulation 118:1612-1618
30. Saxena A, Dinh DT, Smith JA et al (2012) Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients). Am J Cardiol 109:219-225
31. Lehto M, Snapinn S, Dickstein K et al (2005) Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J 26:350-356
32. Kappetein AP, Head SJ, Genereux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve replacement: the valve academic research consortium-2 consensus document. J Am Coll Cardiol 60:1438-1454
33. Frost L, Molgaard H, Christiansen EH et al (1992) Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. Int J Cardiol 36:253-261
34. Holmes DR, Mack MJ, Kaul S et al (2012) ACCF/AATS/SCAI/STS Expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 59:1200-1254
35. Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N-9N
36. Eltchaninoff H, Prat A, Gilard M et al (2011) Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 32:191-197
37. Maesen B, Nijs J, Maessen J, Allessie M, Schotten U (2012) Post-operative atrial fibrillation: a maze of mechanisms. Europace 14:159-174
38. O'Brien B, Pasic M, Kuppe H, Hetzer R, Habazetti H, Kukucka M (2011) A transapical or transluminal approach to aortic valve implantation does not attenuate the inflammatory response. Heart Surg Forum 14:E110-E113
39. Rodes-Cabau J, Webb JG, Cheung A et al (2012) Long-term outcomes following transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol 60:1864-1875
40. Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH (2012) Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8:129-138
41. Hynes BG, Rodés-Cabau J (2012) Transcatheter aortic valve implantation and cerebrovascular events: the current state of the art. Ann N Y Acad Sci 1254:151-163
42. Nombela-Franco L, Webb J, de Jaegere P et al (2012) Timing, predictive factors and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 126:3041-3053
43. Schroeter T, Linke A, Haensig M et al (2012) Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation. Europace 14:1759-1763
44. Neumar RW, Otto CW, Link MS et al (2010) Part 8: adult advanced cardiovascular life support. American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 122(Suppl 3):S729-S767
45. Webb J, Rodes-Cabau J, Fremes S et al (2012) Transcatheter aortic valve implantation: a Canadian cardiovascular society position statement. Can J Cardiol 28:520-528
46. Ussia GP, Scarabelli M, Mule M et al (2011) Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 108:1772-1776
47. Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139-1151
48. Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883-891
49. Lip GY (2011) Implications of the CHA(2)DS(2)-VASc and HAS-BLED scores for thromboprophylaxis in atrial fibrillation. Am J Med 124:111-114
50. Zeymer U, Zahn R, Gerckens U et al (2011) Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of triple-therapy. Eur Heart J 32(Abstract suppl):900